搜索筛选:
搜索耗时1.4162秒,为你在为你在102,285,761篇论文里面共找到 19 篇相符的论文内容
类      型:
[期刊论文] 作者:Daniel Ansari,Roland Andersson, 来源:世界胃肠病学杂志:英文版 年份:2012
肝是主要、第二等的恶意的一个普通地点。为 unresectable 肝癌症,许多本地夺格的治疗被开发了。这些包括例如,经皮的乙醇注射(PEI ) ,经皮的醋酸注射, radiofrequency 脱离(RFA...
[期刊论文] 作者:kerberg,Daniel Ansari,, 来源:生物医学工程(英文) 年份:2017
Background: Surgery may trigger the release of inflammatory factors, including cytokines, growth factors and angiogenic factors, which may stimulate tumor growt...
[期刊论文] 作者:Daniel Akerberg,Daniel Ansari,, 来源:世界胃肠病学杂志:英文版 年份:2016
Pancreatic ductal adenocarcinoma carries a poor prognosis with annual deaths almost matching the reported incidence rates. Surgical resection offers the only po...
[期刊论文] 作者:Daniel Ansari,Roland Andersson,, 来源:World Journal of Gastroenterology 年份:2012
Despite improvements in surgical techniques and adjuvant chemotherapy,the overall mortality rates in pancreatic cancer have generally remained relatively unchan...
[期刊论文] 作者:Daniel Ansari,Roland Andersson,, 来源:World Journal of Gastroenterology 年份:2012
AIM:To assess whether gemcitabine-based combination therapy improves the prognosis of unresectable pancreatic cancer compared with gemcitabine treatment alone.M...
[期刊论文] 作者:Daniel Ansari,Bi-Cheng Chen,Le, 来源:世界胃肠病学杂志:英文版 年份:2012
尽管有在外科的技术和辅助化疗的改进,在胰腺的癌症的全面死亡率通常仍然保持相对未改变, 5 年的幸存率实际上低于 2% 。这篇论文将探讨完成早诊断并且为到象基因,蛋白质, microR......
[期刊论文] 作者:Chen Sun,Daniel Ansari,Roland, 来源:世界胃肠病学杂志:英文版 年份:2012
瞄准:估计基于 gemcitabine 的联合治疗是否改进 unresectable 的预后胰腺的癌症与 gemcitabine 治疗相比独自一个。方法:量的新元分析被承担在局部地先进或变形的胰腺的癌症与...
[期刊论文] 作者:Stina Nordh,Daniel Ansari,Rola, 来源:世界胃肠病学杂志:英文版(电子版) 年份:2014
High human equilibrative nucleoside transporter 1(hENT1)-expression has shown a survival benefit in pancreatic cancer patients treated with gemcitabine in sever...
[期刊论文] 作者:kerberg,Daniel Ansari,Roland Andersson,, 来源:World Journal of Gastroenterology 年份:2016
Pancreatic ductal adenocarcinoma carries a poor prognosis with annual deaths almost matching the reported incidence rates. Surgical resection offers the only po...
[期刊论文] 作者:Daniel Ansari,Adam Gustafsson,Roland Andersson,, 来源:World Journal of Gastroenterology 年份:2015
Pancreatic ductal adenocarcinoma(PDAC) represents the fourth cause of death in cancer and has a 5-year survival of < 5%.Only about 15% of the patients present w...
[期刊论文] 作者:Stina Nordh,Daniel Ansari,Roland Andersson,, 来源:World Journal of Gastroenterology 年份:2014
High human equilibrative nucleoside transporter 1(hENT1)-expression has shown a survival benefit in pancreatic cancer patients treated with gemcitabine in sever...
[期刊论文] 作者:Daniel Ansari,William Torén,Roland Andersson, 来源:肝胆外科与营养 年份:2018
Colorectal cancer (CRC) is a leading cause of death worldwide (1). The liver is the most common site for distant metastases, and approximately 50% of patients di...
[期刊论文] 作者:Ann H Rosendahl,Daniel Ansari,Roland Andersson,, 来源:World Journal of Gastroenterology 年份:2011
Pancreatic cancer,as a highly malignant cancer and the fourth cause of cancer-related death in world,is characterized by dismal prognosis,due to rapid disease p...
[期刊论文] 作者:Chen Sun,Daniel Ansari,Roland Andersson,De-Quan Wu, 来源:世界胃肠病学杂志(英文版) 年份:2012
[期刊论文] 作者:David Ansari,Daniel Ansari,Roland Andersson,?ke Andrén-Sandberg, 来源:肝胆外科与营养 年份:2015
The connection between pancreatic cancer and venous thrombosis has been discussed for almost 150 years. The exact pathophysiological mechanisms are still partly...
[期刊论文] 作者:Chen Sun,Ann H Rosendahl,Daniel Ansari,Roland Andersson, 来源:世界胃肠病学杂志(英文版) 年份:2011
[期刊论文] 作者:Ellen Andersson,Jakob Axelsson,Gunilla Eckerwall,Daniel Ansari,Roland Andersson,, 来源:World Journal of Gastroenterology 年份:2010
AIM: To study tissue factor (TF) in acute pancreatitis and evaluate the role of TF as a predictive marker of severity. METHODS: Forty-nine consecutive patients...
[期刊论文] 作者:Daniel Ansari,Bi-Cheng Chen,Lei Dong,Meng-Tao Zhou,Roland Andersson, 来源:世界胃肠病学杂志(英文版) 年份:2012
[期刊论文] 作者:Henrik Johansson,Roland Andersson,Monika Bauden,Sarah Hammes,Stefan Holdenrieder,Daniel Ansari,, 来源:World Journal of Gastroenterology 年份:2016
Novel treatment modalities are necessary for pancreatic cancer. Immunotherapy with immune checkpoint inhibition has shown effect in other solid tumors, and coul...
相关搜索: